Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. Journal of Pharmacogenomics & Pharmacoproteomics is one of the top open access journals in its field. This journal publishes the study that analyzes how genotype affects an individual's response to drugs. The drug response is calculated based on the genetic variation occurred by correlating gene expression or single-nucleotide polymorphisms. This helps in developing an optimize therapy with respect to drug efficacy or toxicity. Journal of Pharmacogenomics & Pharmacoproteomics is an PrimeOA Publications group open access and peer reviewed journal It creates a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality and reliable manuscripts for the readers and authors of scholarly, academic and scientific field.
The Journal of Pharmacogenomics & Pharmacoproteomics publishes articles on new innovations in the field of personalized medicines. The original research articles or current reviews published under the journal deals with the influence of genetic variations on drug response in patients and viceversa. The journal aims to publish innovations in customized drug discovery using proteome technology. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery. Journal of Pharmacogenomics & Pharmacoproteomics is an open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality, reliable and important articles for the readers and authors of scholarly, academic and scientific field.